---
title: 'Associate Director, Training and Contract Operations at Cogent Biosciences'
canonical: 'https://feeny.ai/job/associate-director-training-and-contract-operations-cogent-biosciences-waltham-0batp7n1zpdd'
type: 'job'
last_seen: '2026-10-14'
---

# Associate Director, Training and Contract Operations at Cogent Biosciences

- **Company:** Cogent Biosciences
- **Location:** Waltham, MA
- **Posted:** 2026-10-08
- **Last confirmed live:** 2026-10-14
- **Apply:** https://job-boards.greenhouse.io/cogentbiosciences/jobs/4438323009

## Job description

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.

The Role:

The Associate Director, Training and Contract Operations holds two core accountabilities that together drive operational excellence across the commercial organization.

The first is direct operational partnership with the Sr. Director, Training & Field Enablement — leading the tactical execution, planning, and governance of commercial training initiatives, field meetings, and enablement programs. This role serves as a critical partner across Sales, Commercial Operations, Marketing, Compliance, Finance, Legal, Procurement, and the People Team to ensure the successful delivery of commercial enablement programs and field-facing events.

The second is ownership of contract operations — facilitating commercial contracts, SOWs, and vendor agreements on behalf of the broader commercial organization as they move through the review and approval lifecycle. This role shepherds, coordinates, and facilitates our commercial contracts ensuring contracts are complete, correctly routed and moving efficiently through the review and approval process.

The balance of time and focus between these two accountabilities will flex based on business need, launch timelines, and organizational priorities. The ideal candidate is a highly organized and influential leader who excels at tactical execution, managing complex vendors and event portfolios, and driving operational excellence through effective cross-functional collaboration.

Responsibilities:

- Commercial Training & Field Operations

Training & Cross-Functional Collaboration

- Oversee execution of commercial training initiatives, onboarding programs, field communications, the training advisory board, and operational projects from planning through implementation
- Build and execute live and virtual training workshops for field and cross-functional commercial partners
- Partner with Sales, Marketing, Medical Affairs, Market Access, Compliance, HR, and Commercial Operations to ensure alignment between training, brand strategy, and field execution
- Support POAs, national meetings, and commercial milestones
- Partner with the Sr. Director, Training & Field Enablement to define the long-term vision, priorities, and evolution of the Commercial Learning function
- Manage multiple high-priority training projects simultaneously while maintaining quality, timeliness, and budget adherence, and continuously evaluate processes to improve efficiency and effectiveness

Meeting Planning & Event Operations

- Support planning and execution of national sales meetings, launch meetings, POA meetings, training workshops, and virtual events
- Manage meeting logistics including venue sourcing, vendor selection, contract negotiation, and budget oversight for events, attendee management, and event execution
- Collaborate with cross-functional stakeholders to develop meeting objectives, agendas, content timelines, and success metrics
- Drive continuous improvement in meeting planning processes and attendee experience

Contract Operations

Central Coordination & Facilitation

- Serve as the operational point of contact facilitating commercial contracts for the broader commercial organization — triaging intake, prioritizing based on business need, and shepherding each agreement through review and approval
- Coordinate between the business and Legal/Procurement, facilitating timely, clear communication and maintaining an aligned signature process with proactive stakeholder heads-up and status alerts

CLM, Efficiency & Enablement

- Own and administer the end-to-end contract workflow within the CLM system (e.g., Agiloft, DocuSign CLM, or equivalent) — intake forms, routing rules, approval workflows, and status tracking — ensuring contracts and amendments remain audit-ready
- Identify and flag contract language with potential business implications ("are we comfortable with this?") and surface synergies or redundancies — same vendors supporting multiple functions, contracts mirroring previously approved terms — building in pre-reviews to prevent late-stage bottlenecks
- Act as "Train the Trainer" on Contracting Excellence — training business submitters and contract owners on process, CLM tool usage, and best practices

Qualifications:

-

- Bachelor's degree required; advanced degree preferred
- 8+ years of experience in Commercial Operations, Training, Field Enablement, Sales Operations, Meeting Planning, Contract Operations, or related functions within biotechnology, pharmaceutical, medical device, or healthcare organizations
- Demonstrated experience coordinating complex contracts and vendor relationships — without owning drafting, negotiation, or risk decisions
- Proven experience leading large-scale meetings and events, including national sales meetings and training programs
- Strong project management and budget management experience
- Experience leading cross-functional initiatives and driving results through influence
- Hands-on experience with a CLM platform (Agiloft, DocuSign CLM, Icertis, ContractPodAi, or similar), including workflow configuration and reporting
- Highly organized, able to manage two distinct accountabilities that shift in weight over time
- Process discipline and comfort owning a workflow end-to-end without owning its content
- Comfortable flagging issues upward without overstepping into Legal or risk-owner territory
- Excellent written and verbal communication across technical (Legal, Procurement) and non-technical (field, Sales) audiences

Salary Range:

$185,000- $220,000USD

Target Bonus: 20%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.

Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.

Our Offer To You

At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

## About Cogent Biosciences

## Company Overview
- **One-liner**: Cogent Biosciences is a publicly traded biotechnology company developing precision therapies for genetically defined diseases, with its lead program bezuclastinib targeting KIT D816V mutations in systemic mastocytosis and gastrointestinal stromal tumors.
- **Entity Type**: Public (NASDAQ: COGT)
- **Headquarters**: Waltham, Massachusetts, United States (with additional office in Boulder, Colorado)
- **Founded**: 2014
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology research and therapeutics development
- **Target customers**: Patients with genetically defined diseases, healthcare providers, and pharmaceutical partners (B2B/B2C hybrid)
- **Mission**: “To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases” [cogentbio.com](https://www.cogentbio.com/)

## Products & Services
- **Bezuclastinib**: A selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation and other KIT exon 17 mutations. In late-stage clinical development for advanced systemic mastocytosis (AdvSM), non‑advanced SM, and advanced gastrointestinal stromal tumors (GIST). Positive registration‑directed trial results reported in 2025. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Novel JAK2 V617F inhibitor**: A potential best‑in‑class mutant‑selective JAK2 inhibitor currently in preclinical development, with data presented at the 2026 EHA Congress. [cogentbio.com](https://www.cogentbio.com/)
- **Additional pipeline programs**: Research‑stage targeted therapies addressing mutations in ErbB2, PI3Kα, KRAS, and JAK2. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Market Standing
- **Valuation/Market Cap**: USD $762.7 million (as of mid‑2026, based on LinkedIn data) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Key Metric**: Annual revenue of USD $7.9 million (likely from partnerships or grants); total funding to date ~USD $1.82 billion (including post‑IPO equity, debt, and Series A). [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Notable Investors/Partners**: Series A led by Atlas Venture and F‑Prime; post‑IPO equity rounds led by Commodore Capital (2024, $225M), Fairmount Funds Management (2020, $104.4M) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Growth Signals**: Headcount grew 27.6% year‑over‑year to 223 employees; monthly LinkedIn follower growth of 3.0% (+61.7% annually); positive late‑stage trial results in 2025; expanded pipeline with new preclinical assets. [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)

## Competitive Advantages
- **Selective targeting of KIT D816V**: Bezuclastinib is designed to selectively and potently inhibit the key driver mutation in systemic mastocytosis, potentially offering a better safety/tolerability profile than earlier multi‑kinase inhibitors.
- **Late‑stage momentum**: Registration‑directed trials (APEX pivotal trial) have reported clinically meaningful results, positioning the company for potential regulatory submissions and commercialization.
- **Broad pipeline beyond KIT**: Research into JAK2, KRAS, PI3Kα, and ErbB2 mutations diversifies the platform and reduces single‑asset risk.
- **Strong capital position**: Over $760M market cap and access to public equity markets provide financial runway for multiple programs.

## Strategic Focus
- **Advance bezuclastinib to market**: Continue regulatory interactions and preparation for potential FDA approval in AdvSM and GIST, while expanding into non‑advanced SM.
- **Build a portfolio of precision therapies**: Invest in early‑stage discovery (Boulder, CO) to generate novel molecules targeting validated oncogenic drivers.
- **Commercial readiness**: Hiring commercial leadership (Chief Commercial Officer, Market Access, Field Medical Affairs) indicates preparation for a future product launch. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Why Work Here
- **Culture**: Emphasizes collaboration, urgency, inquisitiveness, and ingenuity. Corporate values include “Patients are waiting” (urgency), “Learning excites us” (inquisitiveness), “Succeed Together” (trust), and “Navigate uncertainty” (ingenuity). [cogentbio.com](https://www.cogentbio.com/careers/)
- **Work model**: Hybrid/remote flexibility – many roles are listed as remote (e.g., Area Directors for Field Medical Affairs, Patient Educators), while research roles are onsite in Boulder, CO. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Growth and impact**: As a late‑stage clinical company with an expanding pipeline, employees have direct influence on programs that could change patient lives. Fast‑paced environment with high autonomy.

## Sources
1. [Cogent Biosciences Corporate Website](https://www.cogentbio.com/)
2. [Cogent Biosciences About Page](https://www.cogentbio.com/about/)
3. [Cogent Biosciences Careers Page](https://www.cogentbio.com/careers/)
4. [Cogent Biosciences Job Board (Greenhouse)](https://job-boards.greenhouse.io/cogentbiosciences)
5. [Cogent Biosciences LinkedIn Profile](https://www.linkedin.com/company/cogentbiosciences)

## Other roles at Cogent Biosciences

- [Associate Director, Accounting Operations](https://feeny.ai/job/associate-director-accounting-operations-cogent-biosciences-waltham-mnsd4hanythw) — Waltham, MA
- [Senior Associate, Pharmacovigilance Coordinator](https://feeny.ai/job/senior-associate-pharmacovigilance-coordinator-cogent-biosciences-waltham-605v8frhmdj6) — Waltham, MA
- [Manager, Cost Accounting](https://feeny.ai/job/manager-cost-accounting-cogent-biosciences-waltham-r0e52v91m7rb) — Waltham, MA
- [Senior Director, Global Market Access](https://feeny.ai/job/senior-director-global-market-access-cogent-biosciences-waltham-ryr14ebyxz55) — Waltham, MA
- [Scientist, DMPK (BioAnalytical and Medical Writing)](https://feeny.ai/job/scientist-dmpk-bioanalytical-and-medical-writing-cogent-biosciences-boulder-r2b31gdpf60e) — Boulder, CO
- [Director, National Payer Accounts](https://feeny.ai/job/director-national-payer-accounts-cogent-biosciences-waltham-5jkvd1gj4bg7) — Waltham, MA
- [Director, Patient Advocacy & Engagement](https://feeny.ai/job/director-patient-advocacy-engagement-cogent-biosciences-waltham-mdfqz22t61ny) — Waltham, MA
- [Manager, Communications and Investor Relations](https://feeny.ai/job/manager-communications-and-investor-relations-cogent-biosciences-waltham-am68edvhn0v0) — Waltham, MA
- [Associate Director, Translational Medicine](https://feeny.ai/job/associate-director-translational-medicine-cogent-biosciences-waltham-rj8yex8parvp) — Waltham, MA
- [Director, Corporate Counsel](https://feeny.ai/job/director-corporate-counsel-cogent-biosciences-waltham-re6398tj5cwt) — Waltham, MA